How Much Does the Merck CEO Make?
Rob Davis, CEO of Merck, earned $12.0M in total compensation in 2025, including $6.0M in stock awards and $1,200,000 in base salary.
This page answers a common executive-compensation question: How Much Does the Merck CEO Make?. The answer draws on SEC DEF 14A proxy statements, the public disclosure mechanism for U.S. public-company executive pay. Every public company must file an annual proxy statement disclosing CEO and named-executive-officer compensation in detail. Why this matters for shareholders: executive compensation is the single most-disclosed governance metric at U.S. public companies, and the Dodd-Frank-mandated say-on-pay vote gives shareholders an explicit channel to express approval or dissent. Reading pay data well — including pay-versus-performance, peer-group selection, and time-vesting structures — is a basic part of stock-by-stock fundamental analysis.
The detailed answer below uses the actual proxy-statement filings, explains how to read them, and translates the executive-compensation accounting into the shareholder-relevant interpretation.
Rob Davis leads Merck (MRK), a Pharmaceuticals company with approximately 69,000 employees. In the 2025 proxy statement filed with the SEC, Rob Davis's total compensation of $12,000,000 included $1,200,000 in base salary, $0 in cash bonus, $6,000,000 in stock awards, and $1,440,000 in option awards.
The CEO-to-median-worker pay ratio at Merck is 120:1, meaning the CEO earns 120x the median worker's pay of $100,000. Over the past three years, Merck produced a total shareholder return of 11.7% against 4.0% revenue growth. Our Pay-for-Performance Score rates the alignment as B (71/100).
In the most recent say-on-pay vote, 94.6% of shareholders approved the executive compensation plan. Strong shareholder support signals broad approval of the pay package.
Key Data
| Component | Amount |
|---|---|
| Total Compensation | $12,000,000 |
| Base Salary | $1,200,000 |
| Stock Awards | $6,000,000 |
| Option Awards | $1,440,000 |
| Non-Equity Incentive | $1,800,000 |
| CEO-to-Worker Pay Ratio | 120:1 |
| Pay-Performance Grade | B |
Other Pharmaceuticals CEOs
Frequently Asked Questions
Rob Davis, CEO of Merck, earned $12.0M in total compensation in 2025, including $6.0M in stock awards and $1,200,000 in base salary.
Rob Davis is the chief executive officer of Merck (MRK).
The CEO at Merck earns approximately 120 times the median worker's pay of $100,000.
In 2025, total compensation of $12,000,000 was composed of $1,200,000 base salary, $0 cash bonus, $6,000,000 stock awards, $1,440,000 option awards, and $1,800,000 in non-equity incentive compensation.
Our Pay-for-Performance Score rates Merck as B (71/100), based on three-year total shareholder return of 11.7%, revenue growth of 4.0%, and shareholder say-on-pay vote approval.
Rob Davis, CEO of Merck, earned $12.0M in total compensation in 2025, including $6.0M in stock awards and $1,200,000 in base salary.
Source: SEC EDGAR DEF 14A proxy statements, 2026.